WESTBOROUGH, Mass.--(BUSINESS WIRE)--PharmaVigilant, a provider of integrated clinical trial software solutions, announced today that it received Safe Harbor Certification effective April 5, 2011. PharmaVigilant has certified to the U.S. Department of Commerce that it complies with both the U.S.-European Union and the U.S.-Switzerland Safe Harbor Frameworks.
